Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...

CNW/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) today filed its Audited Consolidated ...

TORONTO, March 10, 2026 /CNW/ - Denison Mines Corp. ("Denison" or the "Company") (TSX: DML) (NYSE American: DNN) today filed its Audited Consolidated Financial Statements and Management's Discussion & ...

And myself and Chris will make some remarks to give you an update on the big news from yesterday. So let's start on Page #3. The transaction we announced yesterday was a significant one. We completed ...

Increase in Q4 2025 Revenue to $6.2 Million Introduces Merlin Constellation, a Fully Funded AI-First Global Daily Remapping System at 1-Meter Resolution, Targeted for October 2026 First Launch ...

Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio® ...

Record annual revenue and adjusted EBITDA of $257.8 million and $103.1 million; annual EPS (diluted) $1.43 Strong high -value ...

Detailed price information for North American Construction Group Ltd (NOA-N) from The Globe and Mail including charting and trades.

Commenting on the 2025 results, Jean-François Decaux, Chairman of the Executive Board and Co-CEO of JCDecaux, said: "JCDecaux ...

After more than a year of his chaotic second term, President Donald Trump got a prime time chance to convince Americans the ...

The Company Generated $2.9 Million in Free Cash Flow During the Quarter, Marking Significant Improvements Year Over Year and Sequentially. Over the Past 12 Months, the Company ...

The Company achieved a positive net profit of RMB0.38 billion in the fourth quarter of 2025, recorded a positive net profit for a single quarter for the first time.